(Q35903982)

11 August 2017

title

A retrospective review of the use of alfentanil in a hospital palliative care setting (English)

1 reference

11 August 2017

C E Urch

1

1 reference

11 August 2017

S Carr

series ordinal

2

1 reference

11 August 2017

O Minton

series ordinal

3

1 reference

11 August 2017

publication date

1 September 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

18

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

516-519

1 reference

Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM910OA

Patient-controlled analgesic infusions: alfentanil versus morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM910OA

Randomised double-blind comparison of morphine vs. a morphine-alfentanil combination for patient-controlled analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM910OA

The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM910OA

Intraindividual variability in male hepatic CYP3A4 activity assessed by alfentanil and midazolam clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM910OA

Pharmacokinetic drug interactions of macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM910OA

Inhibition of alfentanil metabolism by erythromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM910OA

Simultaneous assessment of drug interactions with low- and high-extraction opioids: application to parecoxib effects on the pharmacokinetics and pharmacodynamics of fentanyl and alfentanil

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216304PM910OA

10.1191/0269216304PM910OA

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference